MarketInOut Stock Screener Log In | Sign Up

Shanghai Bio-Heart Biological Technology Co Ltd

HKSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Shanghai Bio-Heart Biological Technology Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization254.37 mln
Float106 mln
Earnings Date03/26/2027

Piotroski F-Score

6 / 9
Solid

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.45
Low leverage

Pre-Tax Margin

-263%
Severely loss-making

ROE

-16.98
Negative

Altman Z-Score

-0.86
Deeply distressed

Business Description

Founded in 2014 and based in Shanghai, Bio-heart Biological Technology develops medical devices aimed at treating heart and blood pressure conditions in China. Its main products include a dissolving coronary scaffold, a kidney-based nerve treatment system for hard-to-control high blood pressure, and a drug-coated balloon catheter for reopening previously treated arteries. The company handles both the production and local distribution of these devices.

Key Fundamentals

EPS-0.32
ROE-16.98
RPS0.18
ROIC-11.61
ROA-8.92
Interest Cover-12.00
EBITDA, mln-80.96
EV / EBITDA-4.74
EV / EBIT-3.69
Revenue, mln42.74
EV / Revenue8.98

Quote Details

Last 0.93
Change -0.035 (-3.63%)
Open 0.93
Volume 150,100
Turnover 139,593
Average Volume 80,920

Financial Ratios

Pre-Tax Profit Margin-263
Leverage Ratio1.97
Current Ratio23.75
Price / Book0.53
Price / Tangible Book1.53
Debt / Equity0.45
Price / Sales5.77

Financial Strength

Altman Z-Score-0.86
Piotroski F-Score 6 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -16.22% 5 / 100   
1 Month -32.61% 6 / 100   
2 Months -65.56% 1 / 100   
6 Months -79.83% 2 / 100   
1 Year -85.97% 2 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog